دورية أكاديمية

Increased platelet, leukocyte, and coagulation activation in primary myelofibrosis.

التفاصيل البيبلوغرافية
العنوان: Increased platelet, leukocyte, and coagulation activation in primary myelofibrosis.
المؤلفون: Alvarez-Larrán, Alberto, Arellano-Rodrigo, Eduardo, Reverter, Juan, Domingo, Abel, Villamor, Neus, Colomer, Dolors, Cervantes, Francisco
المصدر: Annals of Hematology; Apr2008, Vol. 87 Issue 4, p269-276, 8p, 5 Charts, 1 Graph
مصطلحات موضوعية: BLOOD platelets, LEUCOCYTES, COAGULATION, MYELOFIBROSIS, POLYCYTHEMIA vera, THROMBOCYTOSIS, ADENOSINE diphosphate
مستخلص: Platelet and leukocyte activation has been demonstrated in polycythemia vera (PV) and essential thrombocythemia (ET), but such information is limited in primary myelofibrosis (PMF). Platelet, leukocyte, endothelial, and coagulation activation status was assessed in 26 PMF patients and compared with data from 22 age- and sex-matched healthy individuals. Study included flow cytometry assessment of platelet P-selectin expression [at baseline and after adenosine diphosphate (ADP), thrombin and arachidonic acid stimulation], platelet–neutrophil and platelet–monocyte complexes, and CD11b expression in neutrophils and monocytes. Additionally, soluble P-selectin, sCD40L, tissue factor, thrombomodulin, prothrombin fragment 1 + 2 (F1 + 2), and D-dimer were measured by enzyme-linked immunosorbent assays. The above parameters were correlated with the patients’ clinical data and presence of the JAK2 V617F mutation. Compared with controls, PMF patients had increased baseline platelet activation, as shown by significantly higher levels of soluble and platelet P-selectin expression, and also higher percentages of platelet–monocyte complexes. Neutrophil and monocyte CD11b expression was significantly higher in patients with the JAK2 mutation than in those with wild-type allele or the controls. Endothelial and coagulation activation, as demonstrated by increased plasma levels of thrombomodulin and F1 + 2, was also found in PMF, with patients with the JAK2 mutation showing significantly higher values of F1 + 2 than those with wild-type allele. In conclusion, PMF patients have platelet, leukocyte, endothelial, and coagulation activation similar to that in PV and ET. CD11b overexpression and F1 + 2 are correlated with the presence of the JAK2 mutation. [ABSTRACT FROM AUTHOR]
Copyright of Annals of Hematology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:09395555
DOI:10.1007/s00277-007-0386-3